Search database
Filter
29
Topics: Leishmaniasis
Featured
Language
Document type
Studies & Reports
8
Guidelines
7
Videos
5
Fact sheets
3
Manuals
2
Resource Platforms
2
Training Material
1
Strategic & Response Plan
1
Countries / Regions
Latin America and the Carribbean
5
Global
4
Brazil
2
Colombia
2
South–East Asia Region
2
Ethiopia
1
India
1
Somalia
1
South Sudan
1
Turkey
1
Kenya
1
Sudan
1
East and Southern Africa
1
Middle East and North Africa
1
Western and Central Europe
1
Paraguay
1
Asia
1
Africa
1
Eastern Europe
1
Authors & Publishers
Drugs for Neglected Diseases initiative DNDi
5
World Health Organization WHO
5
World Health Organisation (WHO)
3
Centers for disease control and prevention CDC
2
BMJ Innovations :234–239. doi:10.1136/bmj
1
Cafasso, J.
1
Center for Disease Control and Prevention CDC
1
Dailymotion
1
Echeverry, M. C.
1
et al
1
European Centre for disease prevention and control (ECDC)
1
Gaona Narváez, J.
1
Gisselle Carolina Gil Zambrano
1
Gualtero Trujillo, S. M.
1
Healthline
1
Khan, J.
1
Kita, K.
1
McGloin, J.
1
Ministerio de la Protección Social, Colombia
1
Ministerio de salud pública y bienestar social, Paraguay
1
Misiones online
1
Nagasaki University School of Tropical Medicine and Global Health
1
Paipilla, K., Castro-Arroyave, D., Grajales,L. et al.
1
Pan American Health Organisation PAHO
1
Pan American Health Organization (PAHO)
1
Pan American Health Organization PAHO
1
Wamai, R.
1
WHO Neglected Tropical Diseases Department
1
World Health Organzation WHO
1
Yamada, H.
1
Ziaggi, G.
1
Publication Years
Category
Leishmaniasis
9
Guidelines
5
Vector Control
2
Studies & Reports
2
Disease Prevention & Control
1
Toolboxes
Capacity Building & Resources
8
Studies & Reports
8
Clinical Aspects & Diagnostics
7
Information & Education Material (IEC)
6
Statistics & Facts
5
Vector control
2
Opportunistic Infections
1
Leishmaniasis
1
Strategies & Roadmaps
1
Capacity Building & Resources
1
During the Programme Managers’ Review Meeting of Central and East Africa and South-East Asia (online meeting, June 2022), experts proposed additional regional and national subtargets related to VL incidence, as defined below. These targets can be revisited as progress is reviewed and access to dia ... more
In 2007, the Sixtieth World Health Assembly adopted resolution WHA60.13 on control of leishmaniasis, urging Member States, among other actions: to strengthen prevention, active detection and treatment of cases of both cutaneous and visceral leishmaniasis in order to decrease the disease burden; and ... more
This report on global leishmaniasis surveillance follows those published in 2016–2023.2–6 Six indicators of leishmaniasis are publicly available from the Global Health Observatory (GHO).7 In addition to the GHO, country profiles with up to 30 indicators are published, with detailed data received ... more
Despite the significant role of vector control in national leishmaniasis control programmes, the programmatic community perceives vector control as the weakest component of leishmaniasis control strategies in terms of resources, scientific evidence of the usefulness of interventions and capacity for ... more
There are 3 main forms of leishmaniases: visceral (the most serious form because it is almost always fatal without treatment), cutaneous (the most common, usually causing skin ulcers), and mucocutaneous (affecting mouth, nose and throat). Leishmaniasis is caused by protozoan parasites which are tra ... more
Visceral leishmaniasis, the most severe form of leishmaniasis also known as kala-azar, is a life-threatening disease caused by Leishmania parasites which are transmitted by female sandflies. Visceral leishmaniasis causes fever, weight loss, spleen and liver enlargement, and, if not treated, death. P ... more
The Leishmaniasis East Africa Platform (LEAP) was established to support the generation of scientific evidence for the development and distribution of new treatments for leishmaniasis in Eastern Africa.
Website last accessed on 04.06.2023 Youtube Video
Video last accessed on 04.06.2023 Video Dailymotion
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited access to health care. HIV co-infected patients with ... more
2nd edition. These guidelines include several notable changes from the first edition. For cutaneous leishmaniasis, ketoconazole has been removed from the list of treatment options; the number of Leishmania species for which there is strong evidence for the efficacy of miltefosine has increased from ... more
Localized cutaneous leishmaniasis and its evolving forms (diffuse cutaneous leishmaniasis, mucosal leishmaniasis and cutaneous leishmaniasis recidivans), together with the sequela of visceral leishmaniasis (post-kala-azar dermal leishmaniasis), account for about one million cases of dermal leishmani ... more
Leishmaniasis is a climate-sensitive disease. Changes in temperature, rainfall, and humidity can have strong impacts on the sandfly vector, altering their distribution and influencing their survival and population sizes. Increased temperatures shorten vector development time, reduce Leishmania para ... more
This technical report presents the epidemiology of human and animal leishmaniases in the EU and its neighbouring countries and concludes that the disease remains widespread and underreported in many countries of southern Europe, northern Africa, and the Middle East and that there is a need to improv ... more
Cutaneous leishmaniasis (CL) is a neglected infectious endemic disease that is transmitted through the bite of a vector insect (sandfly) of the Lutzomyia genus,typical of rural geographical territories, and causes disfiguring skin ulcers and disabilities. It is estimated that CL affects between 600 ... more
Leishmaniasis is a vector-borne disease with a wide variety of parasite species, reservoirs, and vectors involved in transmission. It is caused by different species of the protozoa Leishmania and is transmitted to animals and humans through a bite of insects in the Psychodidae family. Its presence i ... more
In the Region of the Americas, the leishmaniases are a group of diseases caused by various species of Leishmania, which cause a set of clinical syndromes in infected humans that can involve the skin, mucosa, and visceral organs. The spectrum of clinical disease is varied and depends on the interacti ... more
Leishmaniasis is a parasitic disease that is found in parts of the tropics, subtropics, and southern Europe. Leishmaniasis is caused by infection with Leishmania parasites, which are spread by the bite of infected sand flies. There are several different forms of leishmaniasis in people. The most com ... more
The term leishmaniasis encompasses multiple clinical syndromes, including the cutaneous, mucosal, and visceral forms, which result from infection of macrophages in the dermis, in the naso-orpharyngeal mucosa, and throughout the reticuloendothelial system, respectively. The infection can range from a ... more
J Glob Health Sci. 2020 Jun;2(1):e3. A group of enzootic and zoonotic protozoan infections, the leishmaniases constitute among the most severely neglected tropical diseases (NTDs) and are found in all continents except Oceania. Representing the most common infectious diseases, NTDs comprise an open- ... more